Selodenoson Uses, Dosage, Side Effects and more
Selodenoson is under investigation in clinical trial NCT00040001 (Safety and Efficacy Study of an A1-adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation).
| Trade Name | Selodenoson |
| Generic | Selodenoson |
| Selodenoson Other Names | Selodenoson |
| Type | |
| Formula | C17H24N6O4 |
| Weight | Average: 376.417 Monoisotopic: 376.185903277 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
